Organicell Regenerative Medicine, Inc. (BPSR) .
このページで証明された基準:
SharesGrow 総合スコア： 22/100 0/7 項目が合格。
| Year | EPS（希薄化後） | 売上高 | 純利益 | 純利益率 |
|---|---|---|---|---|
| 2012 | $0.00 | $87.15K | $-12.34K | -14.2% |
| 2013 | $0.00 | $82.97K | $-32.18K | -38.8% |
| 2014 | $0.00 | $49.2K | $-65.82K | -133.8% |
| 2015 | $0.00 | $147.63K | $-738.35K | -500.1% |
| 2016 | $-0.01 | $184.88K | $-1.25M | -677.8% |
| 2017 | $-0.08 | $569.85K | $-8.97M | -1574.5% |
| 2018 | $-0.01 | $964.53K | $-3.46M | -358.9% |
| 2019 | $-0.01 | $1.7M | $-1.74M | -102.1% |
| 2020 | $-0.02 | $3.06M | $-12.58M | -411.8% |
| 2025 | $-0.86 | $5.2M | $-5.52M | -106.2% |
